For the first time, the World Health Organization has set out how regulators worldwide should actively enable pharmaceutical decarbonisation. The framework published in late July 2026 shifts the question from […]
Blue Frontier: What the Ocean Is Teaching Life Sciences in 2026
A sea anemone has revealed a way of fighting viruses that runs in the opposite direction to the one in human cells, a peptide from a deep-sea sponge off a […]
Beyond Earth’s Orbit: How Space Exploration Is Rewriting Life Sciences in 2026
A cancer drug that once took a 30-minute hospital infusion can now be delivered by injection in as little as one minute, thanks partly to crystals grown on the International […]
Ear Buds, Real Data: How AirPods Quietly Became a Life Sciences Tool in 2026
Independent researchers in Ireland have confirmed that AirPods Pro 3 can track heart rate almost as accurately as a hospital-grade chest strap, an audiology team has shown that AirPods Pro […]
- August 17, 2026
- By Daniel Molloy-Brookes
- Business
From the Production Line to the Clinic: How the West Midlands’ Driving Heritage Is Reshaping Life Sciences
A £12.5 million programme is paying automotive suppliers to reinvent themselves as medical technology manufacturers, a University of Warwick spin-out is turning decades of engineering research into a national clinical […]
Departures Board: How Travel Became a Life Sciences Laboratory in 2026
A compound tested on jet-lagged mice has cut recovery time nearly in half, wastewater pumped from transatlantic aircraft toilets caught a new coronavirus variant spreading a full month before conventional […]
- August 13, 2026
- By Daniel Molloy-Brookes
- Business
Above the Tree Line: What Hiking and Mountaineering Are Teaching Life Sciences in 2026
A smartwatch tested against a mercury sphygmomanometer at 4,014 metres has just shown exactly where consumer health tech stops being trustworthy, a cargo drone in the Dolomites has cut mountain […]
The Genomic Test That Could Spare Thousands of Breast Cancer Patients From Chemotherapy
For decades, one of the most difficult decisions in breast cancer treatment has been knowing who genuinely needs chemotherapy. Chemotherapy can significantly reduce the risk of cancer returning, but the […]
UK Biotech Funding Hits a Five-Year High: What Is Driving the Recovery?UK biotech investment has just recorded its strongest quarter in five years.
New figures from the BioIndustry Association (BIA) show that UK biotech companies secured £2.11 billion in equity financing between April and June 2026, including a record £2.05 billion in venture […]
The First mRNA Flu Vaccine Has Been Approved. Here Is What That Actually Means.
The FDA cleared Moderna’s mFlusiva on 5 August 2026, making it the first influenza vaccine built on messenger RNA technology to reach the market. The approval completes a turbulent regulatory […]
Mental Health in 2026: A Promising Drug Trial, a System Under Strain and a New Risk Nobody Regulated in Time
A magic mushroom compound delivered in a converted community building has just shown real promise against depression that would not respond to anything else, NHS waiting times are edging down […]
- August 6, 2026
- By Daniel Molloy-Brookes
- Business
Relearning How to Move: The Research, Devices and Infrastructure Reshaping Mobility Rehabilitation
A brain implant that lets a paralysed person feel their own footsteps again, a small NHS hospital building its own robotic arm because nothing on the market quite fits and […]
Dementia in 2026: Diagnosis Is Racing Ahead of Access
A blood test that can flag Alzheimer’s risk a decade before symptoms appear, a UK trial now recruiting patients through memory clinics to bring that test into the NHS and […]
Catching Blood Clots Before They Kill: The Technology Racing to Close an Old Diagnostic Gap
A new PET tracer that can spot clots anywhere in the body from a single scan, a wearable stocking designed to monitor deep vein thrombosis continuously and a UK trial […]
Brain Tumours: Why 2026 Is Emerging as a Turning Point for Research and Treatment
A UK government cancer plan naming brain tumours as a national priority, two vaccine trials reporting results that outstrip historical survival figures and a Scottish-born gene therapy heading into its […]















